SCHEMBL20152197

SCHEMBL20152197

c1ccc(-c2nc3ccccc3n2-n2c3ccccc3c3c4c5ccccc5n(-n5c(-c6ccccc6)nc6ccccc65)c4ccc32)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 3/20 0.54
HPGD P15428 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.48
PDE6D O43924 1/20 0.46
ALDH2 P05091 1/20 0.46
ALDH3A1 P30838 1/20 0.46
KMT2A Q03164 2/20 0.44
HSD17B10 Q99714 4/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
TP53 P04637 3/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.42
POLB P06746 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA1 P30542 1/20 0.42
GAA P10253 1/20 0.41
CASR P41180 1/20 0.41
PDPK1 O15530 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20152219 0.83 HPGD (0.40) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL20152231 0.76 ESR2 (0.65) KDM4EALDH1A1HPGDPDE6DALDH2
SCHEMBL18708370 0.75 ESR1 (0.63) KDM4EALDH1A1HPGDPDE6DALDH2
SCHEMBL20152213 0.73 ESR1 (0.53) KDM4EALDH1A1HPGDPDE6DALDH2
SCHEMBL20152196 0.72 ESR1 (0.59) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL20152220 0.70 ESR1 (0.56) KDM4EALDH1A1HPGDKMT2AESR1
SCHEMBL12145678 0.70 HPGD (1.00) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL15073554 0.70 ESR1 (0.60) KDM4EALDH1A1HPGDKMT2AESR1
SCHEMBL16448092 0.70 ESR1 (0.53) KDM4EALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL20152185 0.69 ESR1 (0.52) KDM4EALDH1A1HPGDKMT2AESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662196-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-05-26 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662196-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, SLCO4C1 KDM4E 3377/4885ALDH1A1 1578/4885HPGD 1331/4885
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, SLCO4C1 KDM4E 3377/4885ALDH1A1 1578/4885HPGD 1331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.